Richard Ginn - Tenon Medical CTO Founder
| TNON Stock | USD 1.79 0.01 0.56% |
Insider
Richard Ginn is CTO Founder of Tenon Medical
| Age | 59 |
| Address | 104 Cooper Court, Los Gatos, CA, United States, 95032 |
| Phone | 408-649-5760 |
| Web | https://www.tenonmed.com |
Tenon Medical Management Efficiency
The company has return on total asset (ROA) of (1.0952) % which means that it has lost $1.0952 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.9862) %, meaning that it created substantial loss on money invested by shareholders. Tenon Medical's management efficiency ratios could be used to measure how well Tenon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of January 2025, Return On Tangible Assets is likely to drop to -2.97. In addition to that, Return On Capital Employed is likely to grow to -5.36. At this time, Tenon Medical's Net Tangible Assets are very stable compared to the past year. As of the 18th of January 2025, Other Current Assets is likely to grow to about 469.7 K, while Total Assets are likely to drop about 6 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Nikolai Kabelev | STRATA Skin Sciences | 48 | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
| Michael Leabman | Movano Inc | 52 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Martha Morrell | Neuropace | 67 | |
| Chad Clouse | Aurora Spine | N/A | |
| Andre Marquette | Neuropace | N/A | |
| John Esq | Ainos Inc | 57 | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| Sam Park | Sight Sciences | 63 | |
| William MBA | STRATA Skin Sciences | 58 | |
| Paul Badawi | Sight Sciences | 50 | |
| David Meyer | Aurora Spine | N/A | |
| John Ordway | Sight Sciences | N/A | |
| Veronica Cai | Tivic Health Systems | 48 | |
| Jennifer Ernst | Tivic Health Systems | 57 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| John Liu | Sight Sciences | N/A | |
| Stacie Rodgers | Sight Sciences | N/A | |
| Michael Favet | Neuropace | 54 | |
| Jesse Selnick | Sight Sciences | N/A | |
Management Performance
| Return On Equity | -15.99 | ||||
| Return On Asset | -1.1 |
Tenon Medical Leadership Team
Elected by the shareholders, the Tenon Medical's board of directors comprises two types of representatives: Tenon Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenon. The board's role is to monitor Tenon Medical's management team and ensure that shareholders' interests are well served. Tenon Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenon Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Foster, President CEO | ||
| Kevin Williamson, Chief Officer | ||
| Richard Ginn, CTO Founder | ||
| Steven Dick, Executive CFO | ||
| Richard Ferrari, Founder Chairman |
Tenon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tenon Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -15.99 | ||||
| Return On Asset | -1.1 | ||||
| Operating Margin | (4.30) % | ||||
| Current Valuation | 699.49 K | ||||
| Shares Outstanding | 3.14 M | ||||
| Shares Owned By Insiders | 1.70 % | ||||
| Shares Owned By Institutions | 1.79 % | ||||
| Number Of Shares Shorted | 64.34 K | ||||
| Price To Book | 1.26 X | ||||
| Price To Sales | 1.67 X |
Pair Trading with Tenon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tenon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Tenon Stock
Moving against Tenon Stock
| 0.88 | VVOS | Vivos Therapeutics | PairCorr |
| 0.87 | GH | Guardant Health | PairCorr |
| 0.87 | ELMD | Electromed | PairCorr |
| 0.85 | EMBC | Embecta Corp | PairCorr |
| 0.84 | DXCM | DexCom Inc | PairCorr |
The ability to find closely correlated positions to Tenon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tenon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tenon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tenon Medical to buy it.
The correlation of Tenon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tenon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tenon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tenon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Tenon Stock, please use our How to Invest in Tenon Medical guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenon Medical. If investors know Tenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 287.92 | Revenue Per Share | Quarterly Revenue Growth 0.213 | Return On Assets | Return On Equity |
The market value of Tenon Medical is measured differently than its book value, which is the value of Tenon that is recorded on the company's balance sheet. Investors also form their own opinion of Tenon Medical's value that differs from its market value or its book value, called intrinsic value, which is Tenon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenon Medical's market value can be influenced by many factors that don't directly affect Tenon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.